In the statement of objections, the Commission included Aventis Pharma SA among the addressees, stating the following reasons for that decision.
Recital 210, Decision_act (EU) 2004/104
In forcesince 27 Nov 2002
In the statement of objections, the Commission included Aventis Pharma SA among the addressees, stating the following reasons for that decision.